Student or educator? Sign up with your school email and get 6 months of Pro free.
CoChat

The DOI matches its Crossref record; 70 of the 73 references it cites were found in a registry or an index; 10 of the 64 sources its claims cite were checked for support.

Acceptability, effectiveness, and cost-effectiveness of internet-based exposure treatment for irritable bowel syndrome in a clinical sample: a randomized controlled trial

Open access

Abstract

Background: Internet-based cognitive behavior therapy (ICBT) has shown promising effects in the treatment of irritable bowel syndrome (IBS). However, to date no study has used a design where participants have been sampled solely from a clinical population. We aimed to investigate the acceptability, effectiveness, and cost-effectiveness of ICBT for IBS using a consecutively recruited sample from a gastroenterological clinic.Methods: Sixty-one patients were randomized to 10 weeks of ICBT (n = 30) or a waiting list control (n = 31). The ICBT was guided by an online therapist and emphasized acceptance of symptoms through exposure and mindfulness training. Severity of IBS symptoms was measured with the Gastrointestinal symptom rating scale - IBS version (GSRS-IBS). Patients in both groups were assessed at pre- and post-treatment while only the ICBT group was assessed 12 months after treatment completion. Health economic data were also gathered at all assessment points and analyzed using bootstrap sampling.Results: Fifty of 61 patients (82%) completed the post-treatment assessment and 20 of 30 patients (67%) in the ICBT group were assessed at 12-month follow-up. The ICBT group demonstrated significantly (p < .001) larger improvements on the IBS-related outcome scales than the waiting list group. The between group effect size on GSRS-IBS was Cohen's d = 0.77 (95% CI: 0.19-1.34). Similar effects were noted on measures of quality of life and IBS-related fear and avoidance behaviors. Improvements in the ICBT group were maintained at 12-month follow-up. The ICBT condition was found to be more cost-effective than the waiting list, with an 87% chance of leading to reduced societal costs combined with clinical effectiveness. The cost-effectiveness was sustained over the 12-month period.Conclusions: ICBT proved to be a cost-effective treatment when delivered to a sample recruited from a gastroenterological clinic. However, many of the included patients dropped out of the study and the overall treatment effects were smaller than previous studies with referred and self-referred samples. ICBT may therefore be acceptable and effective for only a subset of clinical patients. Study dropout seemed to be associated with severe symptoms and large impairment. Objective and empirically validated criteria to select which patients to offer ICBT should be developed.Trial Registration: ClinicalTrials.gov: NCT00844961. © 2011 Ljótsson et al; licensee BioMed Central Ltd.

Overview

CoChat Summary

## TL;DR

This randomized controlled trial tested 10 weeks of therapist-guided internet-based cognitive behavior therapy (ICBT) for irritable bowel syndrome in 61 patients recruited from a gastroenterological clinic. ICBT improved IBS symptoms, quality of life, and IBS-related fear/avoidance more than waiting list, and was judged cost-effective, but dropout was substantial and effects were smaller than in earlier self-referred samples.

## Key findings

  • 61 patients were randomized: 30 to ICBT and 31 to waiting list; 50/61 (82%) completed post-treatment assessment, and 20/30 (67%) in ICBT were assessed at 12 months.
  • The ICBT group had significantly larger improvements than waiting list on IBS outcomes (p < .001); on the primary outcome, GSRS-IBS, the between-group effect size was Cohen’s d = 0.77 (95% CI: 0.19–1.34).
  • Similar improvements were reported for quality of life and IBS-related fear/avoidance; at 12 months, improvements in the ICBT group were maintained, and IBS-QOL showed further improvement (B = 4.5, t20.1 = 2.2, p = .04).
  • ICBT was more cost-effective than waiting list, with an 87% chance of reducing societal costs combined with clinical effectiveness; the paper reports an ICER of -39,821, interpreted as a societal cost reduction of $39,821 per clinically significant improvement.

## Methods

  • Design: Randomized controlled trial with 10 weeks of ICBT versus waiting list; outcomes were assessed pre- and post-treatment, and the ICBT group was followed for 12 months.
  • Sample/data: 61 consecutively recruited IBS patients from a single gastroenterological clinic in Stockholm, Sweden; eligibility required Rome III IBS, age 18–65, Stockholm County residence, and other criteria listed in the paper.
  • Analysis: Primary outcome (GSRS-IBS) and other continuous outcomes were analyzed with linear mixed effects models using FIML; cost-effectiveness used TIC-P data, ANCOVA, paired t-tests, and 5000 bootstrap replications.

## Limitations

  • The paper states that using a waiting list control is an important limitation because it does not control for nonspecific factors such as expectancy and caregiver attention.
  • The trial was not conducted in a fully clinical care context: participants underwent extensive pre-treatment assessment, which the authors say may have contributed to the high dropout rate.
  • The authors note limits to generalizability because they excluded patients with severe diarrhea who were judged to need psychotropic medication, and because cost estimates used estimated salaries rather than actual salaries; they also estimated treatment cost only from therapist time, excluding platform/manual development and clinic overhead.

Model-written summary. Check it against the paper before relying on it.

Integrity signals

Registry

Crossref · 10.1186/1471-230x-11-110

Cites

70 of 70 references verified0 citation errors · 0 not checkable

Statistics

Nothing to recompute.

Figures

Figure 1 Participant flow through the trial.
Figure 1 Participant flow through the trial.CC BY · PubMed Central
Figure 2 Cost-effectiveness plane.
Figure 2 Cost-effectiveness plane.CC BY · PubMed Central

Verification

Claims the paper makes

9 Valid · 2 Not valid · 30 Not checked · 85 Own results and interpretations

58 more claims

Create a free account to see all 126 claims and to verify the 3 references still open.

See all claims — free account
  • Probably not a substantial claim. 36
  • It may state two separate claims as one. 40
  • Borderline: one of the tests for a substantial claim is unclear. 1

Create a free account to see these claims.

Citations

Cites

Show all 73 references

Research works printed but not linked: 1

  1. Haakart-van Roijen L: Manual Trimbos/iMTA questionnaire for costs associated with psychiatric illness. 2002, Rotterdam: Institute for Medical Technology Assessment

Cited by

See all 132

Metadata

Authors
Ljótsson, B., Andersson, G., Andersson, E., Hedman, E., Lindfors, P., Andréewitch, S., Rück, C., & Lindefors, N.
Affiliations
  • Karolinska Institutet (SE)
  • Linköping University (SE)
  • Sabbatsberg Hospital (SE)
Corresponding author
Ljótsson, Brjánn
Venue
BMC Gastroenterology
Published
2011-10-12
Volume
11
Issue
1
Pages
110-110
ISSN
1471-230X (ISSN-L)
OpenAlex
W2123126598
Cited by
132
References
73
Citations by year
2026: 8 · 2025: 6 · 2024: 7 · 2023: 4 · 2022: 10 · 2021: 9 · 2020: 5 · 2019: 5 · 2018: 15 · 2017: 8 · 2016: 3 · 2015: 15 · 2014: 14 · 2013: 13 · 2012: 10
FWCI
12.12
Type
journal article
Language
en
Open access
Licence
  • cc-by
  • creativecommons.org/licenses/by/2.0 (tdm)
Locations
  • BMC Gastroenterology (publishedVersion, cc-by)
  • Europe PMC (PubMed Central) (publishedVersion, cc-by)
  • PubMed Central (publishedVersion, cc-by)
  • PubMed (publishedVersion)
  • DiVA (Linkoping University) (submittedVersion, other-oa)
  • DOAJ (DOAJ: Directory of Open Access Journals) (submittedVersion, cc-by-sa)
Funders
  • Kommunfullmäktige, Stockholms Stad
  • Linköpings Universitet
  • Stockholms Läns Landsting
Topics
  • Health Sciences › Medicine › Gastroenterology › Gastrointestinal motility and disorders
  • Social Sciences › Psychology › Applied Psychology › Digital Mental Health Interventions
  • Social Sciences › Psychology › Experimental and Cognitive Psychology › Anxiety, Depression, Psychometrics, Treatment, Cognitive Processes
Keywords
irritable bowel syndrome, internet-based cognitive behavioral therapy, exposure therapy, mindfulness training, cost-effectiveness, acceptability, treatment discontinuation, quality of life, fear and avoidance, long-term treatment outcomes, patient selection criteria, health economics
MeSH terms
Adult, Cost-Benefit Analysis, Female, Humans, Male, Patient Dropouts, Quality of Life, Severity of Illness Index, Cognitive Behavioral Therapy, Internet, Feedback, Psychological, Irritable Bowel Syndrome

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

The claim verdicts this report counts are experimental: their accuracy is not yet measured.

A language model drew the claims from the paper on 2026-10-11, under version 3 of the claim definition (model deepseek-v4.1-flash, prompt extract-v3).

A second model labelled each claim on 2026-10-11 (model jev-1.13-20260917, definition revision gold-guideline-v0.2).

Cited sources are checked with a language model’s help (gpt-6-sol).

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: Acceptability, effectiveness, and cost-effectiveness of internet-based exposure treatment for irritable bowel syndrome in a clinical sample: a randomized controlled trial. https://app.cochat.ai/papers/10.1186/1471-230x-11-110
The paper
Ljótsson, B., Andersson, G., Andersson, E., Hedman, E., Lindfors, P., Andréewitch, S., Rück, C., & Lindefors, N. (2011). Acceptability, effectiveness, and cost-effectiveness of internet-based exposure treatment for irritable bowel syndrome in a clinical sample: a randomized controlled trial. BMC Gastroenterology. https://doi.org/10.1186/1471-230x-11-110

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.